Skip to content

Drug interactions

Octreotide + Tetrabenazine

Severity: Moderate

Octreotide and Tetrabenazine: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Tetrabenazine causes dose-related QT prolongation. Combined with octreotide, which can cause bradycardia and conduction disturbances, the risk of ventricular arrhythmia may rise.

What this interaction means in plain words

Octreotide and Tetrabenazine can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Octreotide belongs to Endocrine; Tetrabenazine belongs to Central Nervous System.

Evidence level: Low

Why it happens

Additive pharmacodynamic QT prolongation.

What to do

Monitor ECG and electrolytes, particularly after dose increases of tetrabenazine. Avoid in patients with bradycardia, hypokalemia or congenital long QT.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Octreotide and Tetrabenazine, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Octreotide with Tetrabenazine?

MediHelp rates the interaction as moderate. Octreotide and Tetrabenazine can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Tetrabenazine causes dose-related QT prolongation. Combined with octreotide, which can cause bradycardia and conduction disturbances, the risk of ventricular arrhythmia may rise.

How serious is the interaction between Octreotide and Tetrabenazine?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor ECG and electrolytes, particularly after dose increases of tetrabenazine. Avoid in patients with bradycardia, hypokalemia or congenital long QT.

What other medicines interact with Octreotide?

MediHelp also lists interactions of Octreotide with, for example, Adagrasib, Amisulpride, Arsenic trioxide. The full list is on the Octreotide page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in